HPF (John Hancock Preferredome Fund II) Research & Development: $0.00 Mil (TTM As of Jan. 2026)


HPF John Hancock Preferred Income Fund II HPF
31 GF Score
Price $15.73
! 6 Warning Signs
View Full Analysis

What is John Hancock Preferredome Fund II Research & Development?

John Hancock Preferredome Fund II HPF +0.45% 31 Research & Development is $0.00 Mil as of Jan. 2026. GuruFocus rates HPF with a GF Score™ of 31/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. John Hancock Preferredome Fund II's Research & Development for the six months ended in Jan. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00 Mil.


John Hancock Preferredome Fund II  (NYSE:HPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


John Hancock Preferredome Fund II Research & Development Related Terms


John Hancock Preferredome Fund II Research & Development Historical Data

* Premium members only.

The historical data trend for John Hancock Preferredome Fund II's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

John Hancock Preferredome Fund II Research & Development Chart

John Hancock Preferredome Fund II Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

John Hancock Preferredome Fund II Semi-Annual Data
Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HPF
31GF Score
John Hancock Preferred Income Fund II HPF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

John Hancock Preferredome Fund II Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
John Hancock Preferredome Fund II (HPF) has a Research & Development of $0.00 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on John Hancock Preferredome Fund II and its competitors.
Is John Hancock Preferredome Fund II's Research & Development too high?
John Hancock Preferredome Fund II's current Research & Development is $0.00 Mil. Overall, John Hancock Preferredome Fund II has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does John Hancock Preferredome Fund II's Research & Development compare to MIY and EMF?
John Hancock Preferredome Fund II's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on John Hancock Preferredome Fund II and its competitors. John Hancock Preferredome Fund II's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is John Hancock Preferredome Fund II stock overvalued right now?
John Hancock Preferredome Fund II (HPF) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. John Hancock Preferredome Fund II's overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For John Hancock Preferredome Fund II (HPF), the current Research & Development is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

John Hancock Preferredome Fund II Business Description

Address 200 Berkeley Street, Boston, MA, USA, 02116
John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.
31GF Score

Get the complete analysis for HPF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.73
Price